IT
INSIDER · RAPP · Rapport Therapeutics, Inc. · CHIEF FINANCIAL OFFICER
Ignelzi Troy A.
Every open-market transaction filed under this name, Oct 21 to Oct 21.
Filings
1
1 buy · 0 sells
Bought
$144K
open market, at cost
Sold
—
includes scheduled sales
Buys since
−4.0%
avg move from buy price, 1 priced
Filings
| Traded | Ticker | Company | Role | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|---|---|
| Oct 21 | RAPP | Rapport Therapeutics, Inc. | Chief Financial Officer | Buy | 5,500 | $26.10 | $144K | −4.0% |
"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.